IN the presence of specialists in the pharmaceutical industry headed by Professor Sameer Zimmo & Professor Paul Clayton, media practitioners and a group of doctors, pharmacists and those interested in therapeutic nutrition, Jamjoom Pharma Pharmaceutical Company inaugurated in Jeddah and Riyadh, its new product, "Veratol", the first of its kind in Saudi Arabia and the Middle East.

Professor Paul Clayton, Senior Scientific Advisor to the British Government Committee on Drug Safety, as well as his academic work as a lecturer at the Institute of Food, Brain and Behavior at the University of Oxford, gave a scientific lecture on “Resveratrol”, one of the most important ingredients of the new product “Veratol”. Which is the most recent researched molecule in the field of dietary supplements.

The new product comes within the framework of the plans of Jamjoom Pharma for the future expansion of health and beauty products and skin care, which contribute to the safe care of the skin, and protects them from diseases and side effects that are associated with some other products that include fatty or chemical substances.

Yousuf Jamjoom, Sales Development Manager at Jamjoom Pharma, said the launch of Veratol in the market is part of the company's continuous contribution to enrich the Saudi and Gulf markets with high quality, safe, effective and competitively priced products that meet the needs and expectations of consumers. Referring that Jamjoom Pharma has demonstrated its pioneer & well established position as a leading pharmaceutical manufacturer. — SG